Explore the 'Most Read Articles' section on annals.org. Identify the title of the top 'Most Read Article' and its listed authors. Then, navigate to the article titled 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' directly from the homepage and identify its publication date and the first two listed authors.
Navigate to 'https://annals.org'. Locate the 'Most Read Articles' section on the homepage. Identify the title and authors of the first article listed under 'Most Read Articles'. Locate the article titled 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' on the homepage. Click on the link for 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' to navigate to its dedicated page. On the article's page, identify its publication date and the first two listed authors.
The agent successfully navigates to 'https://annals.org'. The agent correctly identifies the title of the top 'Most Read Article' as 'PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and...'. The agent correctly identifies the authors of the top 'Most Read Article' as 'Andrea C. Tricco, PhD, MSc' and 'Erin Lillie, MSc'. The agent successfully navigates to the article page for 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes'. The agent states the publication date of 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes' as '17 June 2025'. The agent states the first two listed authors of 'Semaglutide, Dulaglutide, or Empagliflozin for Diabetes: Mortality and CV Outcomes'.